Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 29.47% | 34.90% | 10.54% | 22.31% | -35.73% |
| Total Depreciation and Amortization | -20.00% | 13.04% | 19.05% | 17.86% | 56.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -42.17% | -21.06% | -10.47% | 14.02% | 49.84% |
| Change in Net Operating Assets | 1,703.57% | 200.00% | -182.53% | -86.21% | -50.00% |
| Cash from Operations | 43.99% | 40.65% | -6.52% | 14.69% | -35.80% |
| Capital Expenditure | -460.00% | 83.87% | -- | 97.73% | 64.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -225.11% | -- |
| Cash from Investing | -51,340.00% | -1,988.71% | 18,118.75% | -227.01% | 64.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.24% | 212.05% | 89.41% | -2,882.35% | -35.16% |